Clariness and Boehringer Ingelheim RCV Partner to Bring New ClinLife Services to Poland and Austria
Clariness GmbH, Hamburg, December 8th, 2021 – Clariness GmbH announces the expansion of its new ClinLife Registry services to Poland and Austria in partnership with Boehringer Ingelheim RCV GmbH. The expansion follows years of patient enrollment support provided through Viomedo and then ClinLife®, following Clariness acquisition of Viomedo in 2018.
This partnership marks Boehringer Ingelheim as one of the first customers to expand its European patient recruitment through ClinLife. The expansion into Poland and Austria accelerates Boehringer Ingelheim’s patient enrollment across a number of indications, including mental illnesses such as borderline and depression.
“Transparency of clinical trials is very important to us at Boehringer Ingelheim. With Clariness we have an experienced partner who helps us to jointly create transparency about ongoing clinical trials for patients in Poland and Austria,” says Hermann Novak, Regional Therapeutic Area Lead CNS, Retinopathies & Emerging Areas at Boehringer Ingelheim RCV.”, said Hermann Novak, Regional Therapeutic Area Lead CNS, Retinopathies & Emerging Areas at Boehringer Ingelheim RCV.
Moritz Kloss, Vice President of ClinLife Registry at Clariness, added that “expanding to new European markets with a partner like Boehringer Ingelheim shows that digital patient recruitment is essential to finding and matching patients with clinical trials moving forward.”
Boehringer Ingelheim RCVs first clinical studies that are conducted in Poland and in Austria are expected to go live on the ClinLife platform by the end of Q4 2021.
Clariness provides high-end services across the clinical trial lifecycle, including study feasibility, patient recruitment, and patient retention services, for pharmaceutical companies, contract research organizations (CROs), and study sites across the globe.
Dedicated to improving patients’ lives by accelerating the development of medical treatments and therapies, Clariness is the leading expert in global patient recruitment with 16+ years’ experience. Clariness has supported over 1,200 clinical trials worldwide through its market leading patient portal ClinLife®, which is active in 50+ countries, available in 35+ languages, covers 80+ indications, and welcomes 15+ million visitors per year.
For more information, visit www.clariness.com and www.clinlife.com
ClinLife® is a patient-friendly digital platform that allows users to browse indications, find matching clinical studies and apply for them via the portal. Different sponsors, sites, CROs and digital health applications list a single study or an entire portfolio of clinical trials on ClinLife.